Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41541-021-00290-y http://scihub22266oqcxt.onion/10.1038/s41541-021-00290-y 33574335!7878788!33574335     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       NPJ+Vaccines 2021 ; 6 (1): 26 Nephropedia Template TP {{tp|p=33574335|t=2021. Promoting versatile vaccine development for emerging pandemics |pdf=|usr=}}{{33574335}} gab.com Text Promoting versatile vaccine development for emerging pandemics JO: NPJ Vaccines http://www.kidney.de/pget.php?&tw=1&pmid=33574335 #FOAvip The ongoing COVID-19 pandemic has demonstrated the importance of rapid and versatile development of emergency medical countermeasures such as vaccines. We discuss the role of platform vaccines and prototype pathogen research in modern vaccine development, and outline how previous pathogen-specific funding approaches can be improved to adequately promote vaccine R&D for emerging pandemics. We present a more comprehensive approach to financing vaccine R&D, which maximises biomedical pandemic preparedness by promoting flexible vaccine platforms and translatable research into prototype pathogens. As the numerous platform-based SARS-CoV-2 vaccines show, funders can accelerate pandemic vaccine development by proactively investing in versatile platform technologies. For certain emerging infectious diseases, where vaccine research can translate to other related pathogens with pandemic potential, investment decisions should reflect the full social value of increasing overall preparedness, rather than just the value of bringing a vaccine to market for individual pathogens. Twit Text FOAVip Promoting versatile vaccine development for emerging pandemics ????NPJ Vaccines http://www.kidney.de/pget.php?&tw=1&pmid=33574335 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33574335 #FOAvip English Wikipedia <ref>{{Cite pmid|33574335}}</ref> Promoting versatile vaccine development for emerging pandemics #MMPMID33574335 Monrad JT; Sandbrink JB; Cherian NG NPJ Vaccines 2021[Feb]; 6 (1): 26 PMID33574335show ga The ongoing COVID-19 pandemic has demonstrated the importance of rapid and versatile development of emergency medical countermeasures such as vaccines. We discuss the role of platform vaccines and prototype pathogen research in modern vaccine development, and outline how previous pathogen-specific funding approaches can be improved to adequately promote vaccine R&D for emerging pandemics. We present a more comprehensive approach to financing vaccine R&D, which maximises biomedical pandemic preparedness by promoting flexible vaccine platforms and translatable research into prototype pathogens. As the numerous platform-based SARS-CoV-2 vaccines show, funders can accelerate pandemic vaccine development by proactively investing in versatile platform technologies. For certain emerging infectious diseases, where vaccine research can translate to other related pathogens with pandemic potential, investment decisions should reflect the full social value of increasing overall preparedness, rather than just the value of bringing a vaccine to market for individual pathogens. äPromoting versatile vaccine development for emerging pandemics (epmc).pdf DeepDyve Pubget Overpricing